At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Responsibilities
* Independently develops, troubleshoots, and maintains complex programs and utilities in accordance with BDSs software development lifecycle procedures
* Provides comprehensive programming leadership and support to clinical development teams
* Ensures quality of BDS deliverables by consistently applying analysis and reporting standards, and driving compliance with regulatory requirements, corporate and departmental SOPs and work practices
* Drives the development and implementation of innovative strategies and technologies for clinical trial programming
* Develops unambiguous and robust programming specifications for internal and external programming work
* Provides technical guidance to statistical programmers and vendors around project conventions, standards, practices, and specifications to ensure integrated computing solutions
* Reviews planning documents (e.g. statistical analysis plans, data presentation plans, data review plans) to ensure clarity, integrity and compliance with requirements and standards
* Models acceptable behaviors and communication with stakeholders to ensure effective partnerships
* Supports a culture of inclusiveness, respect for diversity, and compliance with processes
* Supports and leads improvement initiatives within BDS and serves as a BDS representative on cross-functional initiatives
Qualifications
* Graduate degree in statistics, biostatistics, mathematics, computer science or equivalent experience
* Minimum of 6 years clinical/statistical programming experience within pharmaceutical clinical development
* Significant knowledge of the drug development process, clinical trial methodology, statistics and familiarity with global regulatory requirements for study medication approval
* Extensive knowledge of SAS software (i.e. Base, Stat, Graph components) and general computing techniques in addition to knowledge of R or other statistical software packages within the pharmaceutical industry
* Able to adapt quickly to the changing needs of the organization
* Able to organize multiple work assignments and establish priorities
* Excellent verbal and written communications skills; able to communicate proactively and effectively
US military experience shall be considered towards industry and professional experience requirements.
GBDS
GBDSProgramming
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
New York, New York
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.
It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.
The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.